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Background: Neurally adjusted ventilatory assist (NAVA) delivers pressure in proportion
to diaphragm electrical activity (Eadi). However, each patient responds differently to
NAVA levels. This study aims to examine the matching between tidal volume (Vt) and
patients’ inspiratory demand (Eadi), and to investigate patient-specific response to
various NAVA levels in non-invasively ventilated patients.
Methods: 12 patients were ventilated non-invasively with NAVA using three different
NAVA levels. NAVA100 was set according to the manufacturer’s recommendation to
have similar peak airway pressure as during pressure support. NAVA level was then
adjusted ±50% (NAVA50, NAVA150). Airway pressure, flow and Eadi were recorded for
15 minutes at each NAVA level. The matching of Vt and integral of Eadi (ʃEadi) were
assessed at the different NAVA levels. A metric, Range90, was defined as the 5-95%
range of Vt/ʃEadi ratio to assess matching for each NAVA level. Smaller Range90 values
indicated better matching of supply to demand.
Results: Patients ventilated at NAVA50 had the lowest Range90 with median 25.6 uVs/ml
[Interquartile range (IQR): 15.4-70.4], suggesting that, globally, NAVA50 provided better
matching between ʃEadi and Vt than NAVA100 and NAVA150. However, on a
per-patient basis, 4 patients had the lowest Range90 values in NAVA100, 1 patient at
NAVA150 and 7 patients at NAVA50. Robust coefficient of variation for ʃEadi and Vt
were not different between NAVA levels.
Conclusions: The patient-specific matching between ʃEadi and Vt was variable,
indicating that to obtain the best possible matching, NAVA level setting should be
patient specific. The Range90 concept presented to evaluate Vt/ʃEadi is a physiologic
metric that could help in individual titration of NAVA level.
Keywords: Mechanical ventilation, NAVA, Non-invasive ventilation, Patient-ventilator
interaction, Matching© 2013 Chiew et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Chiew et al. BioMedical Engineering OnLine 2013, 12:61 Page 2 of 11
http://www.biomedical-engineering-online.com/content/12/1/61Introduction
Non-invasive ventilation (NIV) is widely used in cases of acute respiratory failure [1]
and for patients who are considered at risk of post-extubation respiratory failure [2].
However, NIV is usually delivered in pressure support (PS) mode despite the poor
synchronization observed in intensive care unit (ICU) patients [3]. In comparison to
PS, neurally adjusted ventilatory assist (NAVA) ventilation improves patient-ventilator
interaction during invasive and NIV [4-7], and have shown to increase respiratory
variability in comparison to PS [8].
NAVA triggers and cycles off the ventilator based on the patient’s diaphragmatic electrical
activity (Eadi). The amount of pressure delivered by the ventilator is proportional to the
Eadi amplitude [9]. Clinicians can adapt the amount of assist delivered with NAVA by
selecting a NAVA level corresponding to a proportionality factor between instantaneously
recorded Eadi and delivered pressure. Currently, there is limited information about how
to correctly set patient-specific NAVA levels [10-14]. Additionally, implementing the best
described method at the bedside [11] is difficult, potentially limiting the daily use of
NAVA. The best way to adapt NAVA level on a day-to-day basis for individual patients is
also unknown. Moreover, it is likely that each patient responds differently to various
NAVA levels, complicating NAVA selection even further.
The aims of this study were two-fold. The primary goal was to investigate the
matching between patient-specific inspiratory demand (ʃEadi) with ventilatory supply, tidal
volume (Vt) at different NAVA levels during NIV. A second goal was the development of
a new physiological approach for titrating NAVA level setting to the individual patient in
a consistent fashion.Materials and methods
This study analyses Eadi-time, flow-time signal and derived parameters during NIV at
three different NAVA levels. This study was conducted at the University Hospital of
Liege (Liege, Belgium) and Cliniques Universitaires Saint-Luc (Brussels, Belgium). The
Ethics Committees of both participating hospitals approved the study protocol and use
of the data.Patients
The study cohort consisted of 12 non-invasively ventilated ICU patients. Patients were
included in the study if they required NIV because of acute respiratory failure, or at risk
of developing respiratory failure after extubation. Specific exclusion criteria were: 1)
Severe hypoxemia requiring FiO2 > 0.6; 2) hemodynamic instability; 3) patient with a
hiatal hernia or other oesophageal problem; upper gastrointestinal bleeding or any
other contraindication to the insertion of a naso-gastric tube; 4) poor short term prognosis;
and 5) age < 18 years. A summary of the patient demographic information with clinical
diagnosis is shown in Table 1.Ventilator and delivered ventilation
All patients were ventilated with Servo-I ventilators (Maquet, Solna, Sweden) equipped
with a commercially available NAVA module and software version 5.0. NIV was
Table 1 Patient demographic information
Patients Gender Age BMI* SAPSII* Clinical diagnosis
1 F 62 20.27 33 Exacerbation of COPD*
2 F 69 36.73 26 Pneumonia
3 F 56 16.7 33 Exacerbation of COPD
4 M 64 22.49 54 Acute renal failure
5 F 68 23.44 33 Asthma
6 M 75 26.12 34 Sepsis
7 M 87 23.67 28 Exacerbation of COPD
8 M 72 40.04 29 Exacerbation of COPD
9 M 87 27.68 30 Exacerbation of COPD
10 F 64 29.14 29 Cardiogenic pulmonary edema
11 F 79 27.97 30 Pneumonia
12 M 78 27.70 34 Drug intoxication
Median [IQR*] 70.5 [64.0-78.5] 26.9 [23.0-29.0] 31.5 [29.0-33.5]
*COPD Chronic obstruct pulmonary disease, IQR Interquartile range, BMI Body mass index, SAPSII Simplified acute
physiology score.
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order to minimise the occurrence of leaks.Study protocol and recordings
After written informed consent was obtained, the patient’s standard nasogastric tube
was replaced by NAVA tube. For each patient, 15 minutes of continuous recording
(~200-300 breaths) was carried out at NAVA100. This NAVA100 level was set in order
to have similar peak airway pressure (Pin) as in PS mode using the previsualization
system included with the ventilator. Two additional NAVA levels, denoted NAVA50
and NAVA150, that modified the initial NAVA level by ±50%, were used with an
additional 15 minutes of breathing and continuous recordings.
Eadi, airway pressure and flow signals were acquired from the Servo-I ventilator,
sampled at 100Hz using Servo-tracker V4.0 software (Maquet, Solna, Sweden). Positive
end-expiratory pressure (PEEP), FiO2 and inspiratory trigger settings were maintained
constant across each NAVA level for a given patient.Data analysis
Signal processing
The sign of the flow signal defined ventilator pressurisation. Pressurisation was defined
to begin with a positive flow signal and end with a negative signal. Inspiratory tidal
volume (Vt) for each breath was calculated by integrating the flow signal between the
pressurisation beginning and end points. The length of time between these two points
was termed the pressurisation time or inspiratory time (Ti). Breaths with Vt < 50 ml
were discarded from analysis. This selection was made through post hoc analysis of the Vt
distribution, suggesting that breaths with Vt < 50 ml likely corresponded to measurement
artefacts.
The Eadi signal was integrated over the period Ti to obtain ʃEadi, representing
patient inspiratory demand [8]. This approach did not account for the delay between
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signal) and the beginning of ventilator’s pressurization. However, this trigger delay is very
low under NAVA [4], and did not significantly influence these results. By definition, the
inspiration end point corresponded to the time when Eadi signal was decreased to 70% of
the maximum Eadi signal as set in the NAVA software.
Range90 assessment of matching
In this study, ʃEadi was used to represent the intensity of the electrical activity during
patient’s inspiration and thus, is the representation of the intensity of the patient’s
inspiration effort. The resulting inspiratory Vt, corresponded to the supply delivered by
the ventilator according to the patient’s demand. Figure 1 shows an example patient
with demand, ʃEadi and corresponding ventilatory supply,Vt. Thus,Vt/ʃEadi is the ratio
of outcome ventilator supply to patient demand (defined as Neuroventilatory efficiency
[15]), and was assessed for each breath. The width of the 5-95th percentile range of
Vt/ʃEadi as shown in Equation (1) was calculated for each patient and NAVA level to
enable analysis. This width was termed ‘Range90’ and defines a patient-specific metric
characterizing the overall ‘matching’ between ventilator supply and patient demand.
Range90 ¼ 95thVt=∫Eadi−5thVt=∫Eadi ð1Þ
If Vt for each breath were equally matched to the ʃEadi, then the Vt/ʃEadi ratio wouldbe a constant. In contrast, a larger range of the Vt/ʃEadi ratio indicates an inability to
consistently match Vt and ʃEadi. Thus, a smaller value of Range90 indicates consist-
ently better matching of Vt to ʃEadi. Patients with larger values of Range90 have a
higher incidence of inconsistent Vt/ʃEadi breaths, which is a lesser ability to match Vt
and ʃEadi, regardless of the patient-specific ʃEadi. Matching, as captured by Range90, is
thus the ability to match the variability of ventilator supply (Vt) to the variability of pa-
tient’s demand (ʃEadi).
Thus, the ratio of Vt/ʃEadi for each breath and the analysis of its distribution
(Range90) over a given set of NAVA settings for a single patient enable a fair comparison
between different NAVA levels. This simple metric could be calculated in real-time, for
example by implementing dedicated software in the ventilator, to monitor patient-specificFigure 1 Example of a patient’s inspiratory ʃEadi and resulting ventilatory Vt.
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titrate NAVA level. The detail and application of Range90 metric is reported elsewhere
[16] and can also be found the Additional file 1 provided in the manuscript.
Statistical and correlation analysis
For each patient at each NAVA level, median [IQR (Interquartile range)] of ʃEadi, Peak
inspiratory pressure (Pin), Vt, and Ti were calculated. The distributions of ʃEadi, Pin, Vt
and Ti at 3 different NAVA levels were compared using the non-parametric Wilcoxon
rank-sum test as they were not normally distributed. A Pearson’s correlation analysis
was carried out for Vt with ʃEadi at different NAVA levels. Robust coefficient of
variation (CVR = median absolute deviation/ median) was calculated for variability
analysis in each parameter.Results
Table 2 summarizes patients’ ʃEadi, Pin, Vt, and Ti at each NAVA level (median of
medians with interquartile range [IQR]). Overall, NAVA50 had a higher ʃEadi = 18.5 uVs
[IQR: 10.3-23.9] with lower Vt = 525 ml [IQR: 473–573] corresponding to a relatively low
Pin = 15.9 cmH2O [IQR: 12.7-17.6]. In contrast, NAVA150 had lower ʃEadi (11.8 uVs
[IQR: 7.8-17.9]) and higher Vt (630 ml [IQR: 478-721]) with Pin = 22.6 cmH2O
[19.7-27.3]. Ti for NAVA50 was slightly higher at 0.88 s [IQR: 0.72-1.06] compared
to other levels.
Table 3 shows the Range90 values at different NAVA levels and Table 4 presents
Pearson’s correlation coefficients between ʃEadi and the corresponding Vt. Comparing
NAVA ventilation at different NAVA levels in Table 3, the Range90 value for the entire
cohort was the smallest for NAVA50, with a median of 25.6 uVs [IQR: 15.4-70.4]. This
result suggested that NAVA50 provided better matching for the cohort in general, compared
to NAVA100 and NAVA150 where Range90 values were 31.7 uVs [IQR: 18.0-90.9] and
36.4 uVs [IQR: 18.9-109.8], respectively.
Figures 2 and 3 present the Vt-ʃEadi scatter plot and Vt/ʃEadi cumulative distribution
plot for Patients 2, 7 and 10. These particular patients had minimum Range90 values
(best matching) at each different NAVA level. Each Figure section highlights the
patient-specific supply and demand for the specific NAVA level.
Table 5 shows the robust coefficients of variation for patients’ ʃEadi, Pin,Vt and Ti at
each NAVA level (p > 0.05 for all tested parameters). Further details relating to Tables 2
and 5 can be found in the Additional file 1 provided with the manuscript.Table 2 Summary of inspiratory demand, peak inspiratory pressure, tidal volume and
inspiratory time
Median of medians [IQR]
NAVA50 NAVA100 NAVA150
ʃEadi (uVs) 18.5 [10.3-23.9] 13.7 [9.9-23.2] 11.8 [7.8-17.9]
Peak Pressure, Pin (cmH2O) 15.9 [12.7-17.6] 21.4 [16.9-22.9]* 22.6 [19.7-27.3]*
Tidal Volume, Vt (ml) 525 [473-573] 581 [464-671] 630 [478-721]
Inspiratory Time, Ti (second) 0.88 [0.72-1.06] 0.81 [0.68-1.03] 0.81 [0.68-1.01]
* P<0.05 compare to NAVA50.
Table 3 Patients’ Range90 in different NAVA level
Patient Initial NAVA level Range 90 (Vt/ʃEadi)
NAVA50 NAVA100 NAVA150
1 0.2 14.7 8.5 14.0
2 0.6 93.7 38.4 138.6
3 0.2 36.3 16.0 17.1
4 0.8 48.6 110.9 80.9
5 0.4 20.5 84.0 40.2
6 0.6 20.5 22.9 32.5
7 0.8 7.2 24.9 68.0
8 0.4 10.8 12.4 17.4
9 0.4 16.1 19.9 20.4
10 1.0 30.7 47.2 30.5
11 1.0 277.9 97.7 207.2
12 0.5 92.2 141.8 211.9
Median [IQR] 0.55 [0.4-0.8] 25.6 [15.4-70.4] 31.7 [18.0-90.9] 36.4 [18.9-109.8]
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Overall, these results (ʃEadi, Pin,Vt and Ti trend) show that patients behaved in general
as expected from other studies. More importantly, they also show that NAVA level was
highly patient-specific due to significant inter-patient variability. The top and middle
panes of Figure 2 (Patient 2 and 7) provide two examples where NAVA50 was associated
with lower Vt and higher ʃEadi and NAVA150 was associated with higher Vt and lower
ʃEadi. The results for NAVA100 were located between those of NAVA50 and NAVA150.
Schmidt et al. [8] and Patroniti et al. [17] showed that a higher NAVA level resulted
in a lower Eadi magnitude with higher Vt. Higher NAVA level delivers higher pressure,
proportional to the level settings, possibly resulting in higher ventilator supply,Vt. Thus,
the Eadi signal that represents the patient-specific demand may decrease. Hence, the
overall results in our study match other published results [7,11,13,17-19].Table 4 Pearson’s correlation
Patients Pearson’s correlation coefficient (Vt-ʃEadi)
NAVA50 NAVA100 NAVA150
1 0.79 0.81 0.81
2 0.50 0.83 0.76
3 0.73 0.81 0.83
4 0.53 0.79 0.88
5 0.72 0.71 0.77
6 0.72 0.76 0.86
7 0.77 0.87 0.17
8 0.88 0.84 0.93
9 0.91 0.95 0.96
10 0.77 0.78 0.62
11 0.50 0.72 0.67
12 0.84 0.69 0.68
Median [IQR] 0.75 [0.63-0.82] 0.80 [0.74-0.84] 0.79 [0.68-0.87]
Figure 2 Vt-ʃEadi scatter plot. (Top) Patient 2 - NAVA100, (Middle) Patient 7 - NAVA50, (Bottom) Patient
10 - NAVA150. The boxed areas show the breaths included in the 5-95th range.
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variability of ʃEadi, Pin, Vt, and Ti. This result indicates that ventilation at different
NAVA levels results in similar variability [7,11,13,17-19]. Thus, selecting an optimal
NAVA level for a patient based on variability analysis is not suitable.
NAVA levels influence the overall matching (Range90) between patient inspiratory
demand and delivered Vt. Overall, NAVA50 gave the best matching (lowest Range90)
for the entire cohort. However, cohort results can be misleading for individual patients.
More specifically, Patient 10 had a minimum Range90 value at NAVA150, 4 patients
had minimum value at NAVA100 (Patients 1-3, 11) and 7 patients (Patients 4-9, 12) at
Figure 3 Cumulative distribution for Vt/ʃEadi in Range90 analysis. (Top) Patient 2 - NAVA100 has
smaller Range90, (Middle) Patient 7 - NAVA 50 has smaller Range90, (Bottom) Patient 10 - NAVA150 and
NAVA50 have a similar Range90, with NAVA150 smaller.
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considering cohort-based measures.
The results show the clinical potential of using Vt/ʃEadi and the Range90 metric to
titrate patient-specific NAVA level over a heterogeneous patient cohort to obtain the
best possible Vt/ʃEadi matching. Practically, such an approach could be used in real
time if it was implemented in the ventilator to choose the best NAVA level for a given patient
at a given time. This approach could also prove useful for adapting NAVA level over time,
Table 5 Summary of robust coefficient of variation (CVR) inspiratory demand, peak
inspiratory pressure, tidal volume and inspiratory time
CVR, median [IQR]
NAVA50 NAVA100 NAVA150
ʃEadi 0.17 [0.13-0.31] 0.22 [0.14-0.31] 0.19 [0.15-0.32]
Peak Pressure 0.08 [0.06-0.12] 0.11 [0.08-0.14] 0.12 [0.07-0.18]
Tidal Volume 0.12 [0.08-0.19] 0.12 [0.09-0.28] 0.14 [0.09-0.24]
Inspiratory Time 0.08 [0.06-0.11] 0.07 [0.05-0.16] 0.09 [0.06-0.14]
Chiew et al. BioMedical Engineering OnLine 2013, 12:61 Page 9 of 11
http://www.biomedical-engineering-online.com/content/12/1/61during a patient’s stay, and especially during weaning from mechanical ventilation, where
only limited data are currently available [10].
It was observed that several patients had very similar values of Range90 in two different
NAVA levels. Three patients with only ±10% difference were Patient 3 (NAVA100 and
NAVA150), Patient 6 (NAVA50 and NAVA150) and Patient 10 (NAVA50 and NAVA150).
These results indicate that the effect of the different NAVA levels were less significant in
the matching of ventilator supply and patient demand. This finding also indicates that
NAVA level titration through interpolation of Range90 would not be effective as the
supply and demand matching does not correspond linearly to NAVA level. Similarly,
titrating NAVA towards higher or lower levels in some cases (Patients 6 and 10) may be
beneficial in terms of ventilator supply and demand matching.
Figures 2 and 3 show Vt/ʃEadi cumulative distribution and Vt-ʃEadi plots for Patient
2, 7 and 10 with Range90 values at each NAVA level. These 3 patients had minimum
Range90 values at different NAVA levels. More specifically, the Range90 metric sug-
gested that Patient 2 should be ventilated at the original NAVA100 level, Patient 7
could have the original NAVA level of 0.80 reduced by 50% for better matching, and
Patient 10 would be better matched at the higher NAVA150 level.
Correlation coefficients facilitate examination of the relationship between Vt with ʃEadi,
independent of the effects of NAVA level on the magnitude of Eadi signals. The correlation
coefficient between Vt and ʃEadi may potentially be another metric to aid in titrating
NAVA level. The correlation coefficients for different NAVA levels in this study were
similar, indicating that NAVA was able to consistently match supply with demand at
different levels. However, individual patients showed otherwise. For example, Patient 2
(NAVA50), Patient 4 (NAVA50), Patient 7 (NAVA150) and Patient 11 (NAVA50), showed
significantly lower R values compared to other NAVA levels, indicating significant supply
and demand mismatch at a specific patient level. Equally, the small changes in the value
of R between NAVA levels may not be clinically significant, indicating that correlation
coefficient was not as sensitive to changes in NAVA level as the Range90 metric. The
Range90 metric consistently identified Vt/ʃEadi mismatch between NAVA levels
compared to Pearson’s correlation, yielding a potentially more sensitive metric.Limitations
Several potential limitations of this study must be pointed out. First, NAVA100 was
defined to match the value of peak airway pressure during PS as set by clinicians.
However, there was no standardisation of PS settings, and the appropriate level of
assistance remains debated.
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patient-mask interface and can influence delivered Vt. However, for this study, the
mask was tightly attached to the patient by an experienced therapist in order to
minimize the chance of leaks. Additionally, the therapist remained at the bedside during
the whole recording to adapt the mask if necessary. These precautions made major leaks
at the patient mask interface very unlikely.
Only 3 levels of NAVA were explored for each patient, separated by ±50% from the
original NAVA100 level. At ±50%, the absolute changes of NAVA level can be very
small or large depending on initial NAVA level. One consequence of such widely
spaced NAVA levels is that, potentially none of the 3 tested NAVA levels in the trials
were optimal. Thus, a more refined set of NAVA levels might well show a better result
with this metric at a different NAVA level.
Finally, it is important to note that while the Range90 metric showed better matching
for specific NAVA levels, the advantage of using this specific NAVA level is not yet
clinically proven. Prior work has shown better matching of Vt to ʃEadi demand results
in less asynchrony in comparing NAVA ventilation and PS [20]. However, the use of
Range90 to titrate NAVA levels for better physiological outcome remains to be
prospectively tested and the results here show only the sensitivity to different level
settings and inter-patient variability thus demonstrating the potential clinical interest.Conclusions
Based on matching and correlation analysis, it was found that each patient reacted
differently to different NAVA levels. This finding indicates significant inter-patient
variability and patient-specific response. Using the proposed concept of supply and
demand ratios (Range90), more optimal NAVA levels can be found and titrated for each
patient based on the simple Range90 metric. This approach can later be used in real
time to adapt NAVA levels if included in software.
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